Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Vitrolife AB Announces First Day of Trading in Xvivo Perfusion AB Shares


Thursday, 4 Oct 2012 02:30am EDT 

Vitrolife AB announced that Xvivo Perfusion AB was spun off from Vitrolife AB on October 1, 2012 whereby Vitrolife shareholders received one share in Xvivo Perfusion for each share in Vitrolife. Xvivo Perfusion shares have been approved for trade on NASDAQ OMX First North and the first day for trade will be October 8, 2012. 

Company Quote

92.75
-0.25 -0.27%
17 Apr 2014